Madrigal Pharmaceuticals, Inc.
(NASDAQ : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading SNTA News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
4.59%11.1713.5%$294.79m
PRGOPerrigo Co. Plc
0.26%69.096.1%$173.33m
SHPGShire PLC Sponsored ADR
0.45%178.190.4%$164.58m
ENDPEndo International Plc
6.70%11.469.5%$144.45m
MDCOMedicines Company
-1.94%50.0321.2%$122.38m
MNKMallinckrodt Plc
2.80%45.5715.7%$89.68m
JAZZJazz Pharmaceuticals Plc
0.10%146.051.7%$89.10m
UTHRUnited Therapeutics Corporation
-1.72%138.7612.3%$78.48m
PRXLPAREXEL International Corporation
0.56%63.056.5%$65.78m
PCRXPacira Pharmaceuticals, Inc.
0.42%47.6013.6%$63.08m
PTLAPortola Pharmaceuticals, Inc.
-0.13%39.189.6%$46.60m
ICPTIntercept Pharmaceuticals, Inc.
-0.16%115.6123.5%$44.04m
HZNPHorizon Pharma plc
4.93%15.128.5%$43.61m
ICLRICON Plc
0.65%80.723.0%$39.32m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.06%121.408.8%$38.17m

Company Profile

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.